Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Retina (Philadelphia, Pa.)
|
January 15, 2011
The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy
Andrew A Moshfeghi, Thomas A Albini, John W Kitchens, et al.
American Journal of Ophthalmology
|
May 19, 2007
Retinal breaks observed during pars plana vitrectomy
Jeffrey K Moore, John W Kitchens, William E Smiddy, et al.
Journal of Ophthalmic Inflammation and Infection
|
September 19, 2024
Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients
Robert A Sisk, Daniel F Kiernan, David Almeida, et al.
Retina (Philadelphia, Pa.)
|
April 18, 2009
Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior
Andrew A Moshfeghi, Alex K Nugent, Hiroyuki Nomoto, et al.
Retina (Philadelphia, Pa.)
|
March 24, 2017
INTRAVITREAL AFLIBERCEPT INJECTION FOR CHOROIDAL NEOVASCULARIZATION DUE TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME: The HANDLE Study
Brian W Toussaint, John W Kitchens, Dennis M Marcus, et al.
BMJ Open Ophthalmology
|
July 7, 2025
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration
Rishi P Singh, Christina Y Weng, John W Kitchens, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
June 28, 2016
The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema
Darius M Moshfeghi, Peter K Kaiser, Stephan Michels, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
January 6, 2018
PRN Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Ocular Histoplasmosis
Edward H Wood, Ryan J Whitted, Thomas W Stone, et al.
Ophthalmology
|
April 17, 2016
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials
John W Kitchens, Diana V Do, David S Boyer, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 22, 2013
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration
John W Kitchens, Nawal Kassem, William Wood, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Retina (Philadelphia, Pa.)
|
January 15, 2011
The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy
Andrew A Moshfeghi, Thomas A Albini, John W Kitchens, et al.
American Journal of Ophthalmology
|
May 19, 2007
Retinal breaks observed during pars plana vitrectomy
Jeffrey K Moore, John W Kitchens, William E Smiddy, et al.
Journal of Ophthalmic Inflammation and Infection
|
September 19, 2024
Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients
Robert A Sisk, Daniel F Kiernan, David Almeida, et al.
Retina (Philadelphia, Pa.)
|
April 18, 2009
Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior
Andrew A Moshfeghi, Alex K Nugent, Hiroyuki Nomoto, et al.
Retina (Philadelphia, Pa.)
|
March 24, 2017
INTRAVITREAL AFLIBERCEPT INJECTION FOR CHOROIDAL NEOVASCULARIZATION DUE TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME: The HANDLE Study
Brian W Toussaint, John W Kitchens, Dennis M Marcus, et al.
BMJ Open Ophthalmology
|
July 7, 2025
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration
Rishi P Singh, Christina Y Weng, John W Kitchens, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
June 28, 2016
The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema
Darius M Moshfeghi, Peter K Kaiser, Stephan Michels, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
January 6, 2018
PRN Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Ocular Histoplasmosis
Edward H Wood, Ryan J Whitted, Thomas W Stone, et al.
Ophthalmology
|
April 17, 2016
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials
John W Kitchens, Diana V Do, David S Boyer, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
October 22, 2013
A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration
John W Kitchens, Nawal Kassem, William Wood, et al.
Page
of 3